The Recall Desk
ModerateFDA (Devices)·Z-1029-2026·Announced 2026-01-14

Intracranial pressure monitors recalled after customer complaints of rebooting

Sophysa is recalling 105 Pressio 2 ICP Monitoring Systems following customer complaints of the Pressio monitor rebooting.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: Scored 2 because the record cites complaints of the monitor rebooting with no stated consequence or reported harm.

Plain-English summary

The Pressio 2 ICP Monitoring System, model number PSO-4000, an intracranial pressure monitor, is being recalled by Sophysa.

The reason given in the enforcement record is customer complaints of the Pressio monitor rebooting.

The record lists 105 units carrying UDI/DI 03760124132076, covering all monitors. Distribution was nationwide in the United States, in Arizona, Wisconsin, Texas, Oregon, California, Oklahoma, Idaho, Florida and New Jersey. The FDA has classified the action as Class II.

The record describes a rebooting monitor and states no further consequence or reported injuries. Facilities should follow Sophysa's instructions.

The recalled product

Product
The Pressio 2 ICP Monitoring System, Model Number PSO-4000; Intracranial Pressure Monitor
Manufacturer
Sophysa
Hazard
  • rebooting
  • monitor-fault

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • UDI/DI 03760124132076
  • All monitors

Distribution

Distributed nationwide across the United States.